INTERFERON-ALPHA AND TRANSFER-FACTOR IN THE TREATMENT OF MULTIPLE-SCLEROSIS - A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL

被引：0
|
作者：
MCLEOD, JG
机构：
来源：
RECENT ADVANCES IN MULTIPLE SCLEROSIS THERAPY | 1989年 / 863卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：125 / 130
页数：6
相关论文
共 50 条
  • [1] INTERFERON-ALPHA AND TRANSFER-FACTOR IN THE TREATMENT OF MULTIPLE-SCLEROSIS - A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
    MCLEOD, JG
    MULTIPLE SCLEROSIS RESEARCH, 1989, 843 : 261 - 266
  • [2] INTERFERON-ALPHA AND TRANSFER-FACTOR IN THE TREATMENT OF MULTIPLE-SCLEROSIS - A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
    FRITH, JA
    HALLPIKE, JF
    CHAMBERS, BR
    DANTA, G
    GRAINGER, KMR
    HAMMOND, SR
    HARRIS, G
    REID, AC
    SYMINGTON, G
    WALSH, JC
    WILLIAMS, DB
    YEO, PT
    MACKAY, IR
    BASTEN, A
    BRADLEY, J
    DAWKINS, RL
    ENGLISH, D
    LOWENTHAL, RM
    VANDERBRINK, CM
    MCLEOD, JG
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1989, 52 (05): : 566 - 574
  • [3] ALPHA-INTERFERON AND TRANSFER-FACTOR IN THE TREATMENT OF MULTIPLE-SCLEROSIS - A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
    FRITH, JA
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1988, 18 (03): : 464 - 464
  • [4] DOUBLE-BLIND TRIAL OF TRANSFER-FACTOR VS PLACEBO IN MULTIPLE-SCLEROSIS PATIENTS
    COLLINS, RC
    ESPINOZA, LR
    PLANK, CR
    EBERS, GC
    ROSENBERG, RA
    ZABRISKIE, JB
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1978, 33 (01): : 1 - 11
  • [5] A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF TIZANIDINE IN THE TREATMENT OF SPASTICITY CAUSED BY MULTIPLE-SCLEROSIS
    BARNES, MP
    BATES, D
    CORSTON, RN
    CROWDER, D
    DICK, DJ
    EMRE, M
    FINDLEY, LJ
    WOOD, H
    HAWKES, CH
    HAWKINS, SA
    HUDGSON, P
    KENDALL, F
    JEWITT, K
    MOFFAT, B
    MILLAC, P
    PARK, D
    PERKIN, GD
    ROBERTS, R
    SAGAR, H
    SPOKES, E
    NEUROLOGY, 1994, 44 (11) : 70 - 78
  • [6] TIZANIDINE TREATMENT OF SPASTICITY CAUSED BY MULTIPLE-SCLEROSIS - RESULTS OF A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
    SMITH, C
    BIRNBAUM, G
    CARTER, JL
    GREENSTEIN, J
    LUBLIN, FD
    BAUMEL, B
    HSU, CY
    MURPHY, F
    READER, AT
    SCHAPIRO, RT
    SIBLEY, WA
    STAZIO, A
    TROTTER, JL
    VOLLMER, TL
    WALSHE, TM
    NEUROLOGY, 1994, 44 (11) : 34 - 43
  • [7] HYPERBARIC-OXYGEN AND MULTIPLE-SCLEROSIS, RESULTS OF A PLACEBO-CONTROLLED, DOUBLE-BLIND TRIAL
    BARNES, MP
    BATES, D
    CARTLIDGE, NEF
    FRENCH, DM
    SHAW, DA
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1986, 49 (06): : 730 - 730
  • [8] A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF INFLUENZA IMMUNIZATION IN MULTIPLE-SCLEROSIS
    MILLER, AE
    MORGANTE, LA
    BUCHWALD, LY
    NUTILE, SM
    COYLE, PK
    KRUPP, LB
    DOSCHER, CA
    LUBLIN, FD
    KNOBLER, RL
    TRANTAS, F
    KELLEY, L
    SMITH, CR
    LAROCCA, N
    LOPEZ, S
    NEUROLOGY, 1995, 45 (04) : A436 - A436
  • [9] DOUBLE-BLIND, CONTROLLED TRIAL OF IMMUNOSUPPRESSION IN TREATMENT OF MULTIPLE-SCLEROSIS
    MERTIN, J
    KNIGHT, SC
    RUDGE, P
    THOMPSON, EJ
    HEALY, MJR
    LANCET, 1980, 2 (8201): : 949 - 951
  • [10] DOUBLE-BLIND CONTROLLED TRIAL OF AZATHIOPRINE IN THE TREATMENT OF MULTIPLE-SCLEROSIS
    不详
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1987, 50 (10): : 1387 - 1387
12345